Inve US ▾
SNSNDL

SNDL (SNDL) Q2 FY26 earnings call: guidance and Q&A

Earnings call· Jun 2026 (Q2 FY26)· Health Care· Jul 28, 2026

Source: earnings call transcript

Executive summary

SNDL Q2 FY26 — Strategic Restructuring and Share Repurchases Amidst Market Headwinds

SNDL navigated a challenging Q2 FY26 marked by market headwinds in both liquor and cannabis, leading to revenue and gross profit declines. Despite these pressures, the company demonstrated financial discipline through accelerated share repurchases and maintained a strong cash position. A significant milestone was achieved with the Parallel restructuring, opening direct access to the US medical cannabis market and providing a platform for future growth and strategic optionality.

Highlights

5

  • Repurchased 11.7 million common shares for $23.3 million (US$1.43/share) in Q2 FY26, contributing to a 7% reduction in shares outstanding since Q4 FY24.

  • Maintained a strong balance sheet with $183.2 million of unrestricted cash and no outstanding debt as of June 30, 2026.

  • Completed the Parallel restructuring, providing direct exposure to US medical cannabis operations with expected near-term annualized revenue of approximately $150 million.

  • Improved free cash flow to negative $6.7 million, a $1.2 million year-over-year improvement despite seasonal payments.

  • Implemented profit enhancement initiatives expected to drive more than $20 million of incremental operating income.

Concerns

5

  • Net revenue declined 3.7% year-over-year to $235.8 million due to persistent demand softness and broader market headwinds.

  • Gross profit declined 16.6% year-over-year to $56.3 million, with gross margin down 3.7 percentage points to 23.9%.

  • Cannabis operations gross margin declined 24 percentage points to 1.8%, primarily due to significant inefficiencies from the Jitter production ramp-up.

  • Liquor retail net revenue declined 5.1% year-over-year to $134.7 million, driven by persistent market demand softness and a 6.2% decline in same-store sales.

  • Adjusted operating loss was $7 million, a $12.8 million year-over-year decline.

Guidance & targets

CategoryTargetConfidence
Incremental operating income from profit enhancement initiatives
more than $20 million
medium materiality
High
Parallel annualized revenue
approximately $150 million
high materiality
High
Parallel annual revenue potential
exceed $1 billion Canadian
high materiality
Medium
Jitter production ramp-up cost headwinds
persist
medium materiality
High
Free cash flow
positive
high materiality
High
Cannabis retail market growth (Alberta and Ontario)
low single digits
medium materiality
Medium
Liquor retail margins
flat or going back to growth
medium materiality
Medium

Segment performance

SegmentRevenueYoYQoQMargin
Consolidated
Net revenue declined due to persistent demand softness and broader market headwinds across both liquor and cannabis segments.
$235.8 million-3.7%——
Liquor Retail
Decline driven by persistent softness in market demand and increased promotional activity. Partially offset by two new YNAB Yonah stores and strong private label sales.
Net revenue decline: $7.2 millionSame-store sales: -6.2%Private label sales: outperformed national brands by 13 percentage pointsGross profit: $33.8 millionGross profit growth YoY: -7.4%Gross margin: 25.1%Gross margin change: -60 basis pointsAdjusted Operating Income change YoY: -$3.5 million
$134.7 million-5.1%—$3.2 million (Adjusted Operating Income)
Cannabis Retail
Decline driven by market contraction in Alberta and Ontario, partially offset by new store openings and value-backed store conversions. Margin expansion supported by promotional efficiencies, pricing actions, and product mix management.
Net revenue decline: $1.2 millionNegative same-store sales: -4.6%Gross profit: $22 millionGross profit change YoY: +$0.1 millionGross margin: 26.4%Gross margin change: +50 basis pointsAdjusted Operating Income change YoY: -$1.2 million
$83.2 million-1.4%—$3 million (Adjusted Operating Income)
Cannabis Operations
Decline driven by market headwinds and absence of B2B flower deliveries. Gross margin significantly impacted by inefficiencies from Jitter production ramp-up.
Net revenue decline: $3.6 millionInternational sales: $5 millionInternational sales growth: +$1.2 millionGross profit: $0.6 millionGross profit change YoY: -$8.7 millionGross margin: 1.8%Gross margin change: -24 percentage pointsAdjusted Operating Loss change YoY: -$6.2 million (from -$2.8 million to -$9 million)
$32.2 million-10.1%—-$9 million (Adjusted Operating Loss)
Investments
Impacted adjusted operating income due to a Sunstream valuation adjustment.
Sunstream valuation adjustment: -$2.3 millionPortfolio carrying value: $415.2 million
————
Corporate
Improved adjusted operating income due to lower corporate overhead costs.
Adjusted operating income improvement: $1.4 millionLower corporate overhead costs
————

Deals & partnerships

Parallel Restructuring of a legacy credit investment, converting a distressed credit position into significant economic exposure to US medical cannabis operations. multi-year

Subject to satisfying remaining legal, regulatory, accounting, and NASDAQ requirements for direct control. Establishes a stronger foundation for future performance of the business.

Risks & headwinds

Persistent market demand softness Q2 FY26, expected to continue for liquor retail for next couple of years

Net revenue declined 3.7% year-over-year to $235.8 million. Liquor retail same-store sales down 6.2%. Cannabis retail same-store sales down 4.6%.

Mitigation:Discipline execution, cost optimization, profit enhancement initiatives, improved promotional discipline, operational efficiency, selective investments.

Cannabis operations production inefficiencies Expected to persist over the coming months

Gross margin declined 24 percentage points to 1.8%. 80-90% of the gross margin shortfall in cannabis operations was due to Jitter ramp-up.

Mitigation:Working closely with partners to implement process improvements and increase labor efficiency.

Increased promotional activity in Liquor Retail Q2 FY26

Gross margin down 60 basis points to 25.1%.

Mitigation:Not making the same level of investments in productivity in the second half of the year, expecting margins to be flat or grow.

Sunstream valuation adjustment Q2 FY26

$2.3 million reduction impacting adjusted operating income.

What to watch in Q3 FY26

Jitter production ramp-up cost headwinds

Coming months (Q3 FY26)
Current 80-90% of cannabis operations gross margin shortfall
Target Reduced impact, improved efficiency

Why it matters

Critical for cannabis operations profitability and overall gross margin recovery.

While we're working closely with our partners to implement process improvements and increase labor efficiency, some of these cost headwinds are expected to persist over the coming months.

Find out whether SNDL delivers this. Inve re-checks your case every morning.

Q&A highlights

Will the capital allocation strategy shift from share repurchases to US investments (M&A, CapEx) now that direct US market access is imminent?

Zach George stated that share repurchases remain attractive due to the equity trading below intrinsic value. The company's debt-free balance sheet and access to competitive debt capital (mid-single digits from Canadian banks) provide a cost of capital advantage. They intend to invest in the US, including improving processing capabilities in Florida and exploring opportunities in Texas, which saw a 40% revenue bump from vape introduction.

“We still have the view that our equity is trading well below its intrinsic value. And when we look at investments that are available to us across the sector, It's still an attractive use of capital to reduce our outstanding share count.”

asked by Aaron Gray · answered by Zachary George

2 min read 6 chapters

Detailed narrative

Market Headwinds and Financial Performance

SNDL faced persistent demand softness across its liquor and cannabis segments in Q2 FY26, resulting in a 3.7% year-over-year net revenue decline to $235.8 million. Gross profit decreased by 16.6% to $56.3 million, with gross margin contracting by 3.7 percentage points to 23.9%. The company reported an adjusted operating loss of $7 million, a $12.8 million year-over-year decline, primarily due to lower gross profit, production ramp-up costs in cannabis operations, and a Sunstream valuation adjustment.

Strategic Balance Sheet and Capital Allocation

Despite market challenges, SNDL maintained a robust balance sheet with $183.2 million in unrestricted cash and no outstanding debt as of June 30, 2026. The company accelerated its share repurchase program, buying back 11.7 million common shares for $23.3 million (US$1.43/share) in Q2, contributing to a 7% reduction in shares outstanding since Q4 FY24. Management views this as a disciplined capital allocation strategy, reflecting confidence in the company's intrinsic value and long-term prospects.

Parallel Restructuring and US Market Entry

A significant strategic milestone was the completion of the Parallel restructuring. This transaction provides SNDL with direct exposure to US medical cannabis operations in Florida, Texas, and Massachusetts, encompassing 56 retail locations and three cultivation/manufacturing sites. These operations are expected to generate approximately $150 million in near-term annualized revenue and offer the potential to exceed $1 billion in annual revenue, positioning SNDL to become a leading global cannabis retailer by store count.

Cannabis Operations Challenges and Outlook

The cannabis operations segment experienced a 10.1% net revenue decline to $32.2 million and a substantial gross margin contraction of 24 percentage points to 1.8%. This was largely attributed to significant inefficiencies from the Jitter production ramp-up, with 80-90% of the gross margin shortfall linked to this issue. Management expects these cost headwinds to persist in the coming months but believes the challenges are fixable, aiming for positive free cash flow for the full calendar year.

Liquor Retail Performance and Strategy

Liquor retail net revenue decreased by 5.1% year-over-year to $134.7 million, driven by persistent market demand softness and a 6.2% decline in same-store sales. Gross profit for the segment was $33.8 million, down 7.4%, with margin compression due to increased promotional activity. Despite the tough global environment for liquor, the company is focusing on improving performance within its convenience banner and leveraging the growth of its Wine and Beyond banner and private label sales.

Cannabis Retail Dynamics

Cannabis retail net revenue saw a modest 1.4% decline to $83.2 million, primarily due to market contraction in Alberta and Ontario, reflected in a 4.6% negative same-store sales. However, gross margin expanded by 50 basis points to 26.4% due to promotional efficiencies and product mix management. Management anticipates a return to low single-digit growth in the second half of the year for this segment, driven by reduced promotional intensity and market stabilization.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.